Assessment of effects of lipid-lowering drugs on hemostasis

被引:2
作者
Altman, R [1 ]
机构
[1] Ctr Estudios Med & Bioquim, Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0002-9149(98)00270-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:73F / 74F
页数:2
相关论文
共 13 条
[1]   LOVASTATIN THERAPY IN HYPERCHOLESTEROLEMIA - EFFECT ON FIBRINOGEN, HEMORRHEOLOGIC PARAMETERS, PLATELET ACTIVITY, AND RED-BLOOD-CELL MORPHOLOGY [J].
BEIGEL, Y ;
FUCHS, J ;
SNIR, M ;
GREEN, P ;
LURIE, Y ;
DJALDETTI, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) :512-517
[2]   AUTOLOGOUS LOW-DENSITY-LIPOPROTEIN ENHANCES PLATELET-AGGREGATION IN WHOLE-BLOOD, AS MEASURED BY INVITRO FILTRAGOMETRY [J].
BROIJERSEN, A ;
WALLEN, NH ;
VITOLS, S ;
LARSSON, PT ;
HJEMDAHL, P .
PLATELETS, 1993, 4 (01) :11-15
[3]   INCREASED THROMBOXANE BIOSYNTHESIS IN TYPE-IIA HYPERCHOLESTEROLEMIA [J].
DAVI, G ;
AVERNA, M ;
CATALANO, I ;
BARBAGALLO, C ;
GANCI, A ;
NOTARBARTOLO, A ;
CIABATTONI, G ;
PATRONO, C .
CIRCULATION, 1992, 85 (05) :1792-1798
[4]  
HALLER H, 1994, J LAB CLIN MED, V124, P708
[5]   LOVASTATIN DECREASES PLASMA AND PLATELET CHOLESTEROL LEVELS AND NORMALIZES ELEVATED PLATELET FLUIDITY AND AGGREGATION IN HYPERCHOLESTEROLEMIC PATIENTS [J].
HOCHGRAF, E ;
LEVY, Y ;
AVIRAM, M ;
BROOK, JG ;
COGAN, U .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (01) :11-17
[6]   EFFECTS OF LOVASTATIN THERAPY ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS [J].
ISAACSOHN, JL ;
SETARO, JF ;
NICHOLAS, C ;
DAVEY, JA ;
DIOTALEVI, LJ ;
CHRISTIANSON, DS ;
LISKOV, E ;
STEIN, EA ;
BLACK, HR .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (07) :735-737
[7]  
LIJNEN P, 1994, J HYPERTENS, V12, P59
[8]   RELATIONSHIPS BETWEEN SERUM-LIPIDS, SEROTONIN, PLATELET-AGGREGATION AND SOME FIBRINOLYTIC PARAMETERS IN HUMANS [J].
MALYSZKO, J ;
URANO, T ;
KNOFLER, R ;
IHARA, H ;
TAKADA, Y ;
TAKADA, A .
LIFE SCIENCES, 1994, 55 (21) :1619-1623
[9]   LIPOPROTEINS AND THE HEMOSTATIC SYSTEM IN ATHEROTHROMBOTIC DISORDERS [J].
MILLER, GJ .
BAILLIERES CLINICAL HAEMATOLOGY, 1994, 7 (03) :713-732
[10]  
PAZZUCCONI F, 1992, EUR J CLIN PHARMACOL, V43, P219